Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP/GLP-1 receptor agonist that significantly reduces appetite and alters eating patterns
While this largely depends on your personal plan, many significant insurance companies now accept semaglutide as a vital weight management treatment
Its this fact that tirzepatide mimics two hormones instead of one that is the main difference between semaglutide and tirzepatide
Switching to Tirzepatide felt like starting fresh
Keep regular follow-ups early after starting treatment and after dose changes
US$ 20.25
US$ 24.65
US$ 20.72
